Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21468304 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  A Study of Zidovudine/Lamivudine and Either Nevirapine or Nelfinavir for Reduction of Mother-to-child HIV Transmission During Breastfeeding
Condition: HIV Infections
Interventions: Drug: Zidovudine/Lamivudine and either Nevirapine or Nelfinavir;   Behavioral: Breastfeeding for 6 months postpartum

Indicates status has not been verified in more than two years